Pete Olson

Pete Olson Peter Graham Olson (born December 9, 1962) is an American politician who served as the U.S. representative for from 2009 to 2021. His district included much of southern Houston, as well as most of the city's southwestern suburbs such as Katy, Pearland, and Sugar Land. He is a member of the Republican Party. On July 25, 2019, Olson announced that he would retire at the end of his term. He was succeeded by fellow Republican Troy Nehls. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Peter Olson', query time: 0.02s Refine Results
  1. 1
    Cardiac Sarcoidosis or Giant Cell Myocarditis? On Treatment Improvement of Fulminant Myocarditis as Demonstrated by Cardiovascular Magnetic Resonance Imaging

    Cardiac Sarcoidosis or Giant Cell Myocarditis? On Treatment Improvement of Fulminant Myocarditis as Demonstrated by Cardiovascular Magnetic Resonance Imaging by Hari Bogabathina, Peter Olson, Vikas K. Rathi, Robert W. W. Biederman

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial

    Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial by Pavlos Msaouel, Kai Yu, Ying Yuan, Jianfeng Chen, Xinmiao Yan, Menuka Karki, Fei Duan, Rahul A. Sheth, Priya Rao, Kanishka Sircar, Amishi Y. Shah, Amado J. Zurita, Giannicola Genovese, Min Li, Chih-Chen Yeh, Minghao Dang, Guangchun Han, Yanshuo Chu, Max Hallin, Peter Olson, Rui Yang, Daniela Slavin, Hirak Der-Torossian, Curtis D. Chin, Nizar M. Tannir, Linghua Wang, Jianjun Gao

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

    Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study by David Goldstein, Anna Spreafico, Ilan Weinreb, Trevor J. Pugh, Scott V Bratman, Bayardo Perez-Ordonez, Aaron R Hansen, Lillian Siu, Antony Tin, Alexey Aleshin, Amy Prawira, Jonathan Irish, John de Almeida, Douglas Chepeha, Stephen Smith, Marc Oliva, Daniel V Araujo, J. Javier Diaz-Mejia, Peter Olson, Tina Shek, Andrew Hope, Dax Torti, Jeffrey P. Bruce, Ben X. Wang, Anthony Fortuna, Hirak Der-Torossian, Ronald Shazer, Nickolas Attanasio, Qingyan Au, Jordan Feeney, Himanshu Sethi, Isan Chen

    Published 2021-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: